University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Clinical Pathology
  • Clinical Pathology - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Clinical Pathology
  • Clinical Pathology - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    PALB2 and breast cancer: ready for clinical translation!

    Thumbnail
    Download
    Published version (311.3Kb)

    Citations
    Scopus
    Altmetric
    35
    Author
    Southey, MC; Teo, ZL; Winship, I
    Date
    2013
    Source Title
    Appl Clin Genet
    Publisher
    Informa UK Limited
    University of Melbourne Author/s
    Southey, Melissa; Winship, Ingrid; Teo, Zhi Ling
    Affiliation
    Clinical Pathology
    Medicine and Radiology
    Sir Peter MacCallum Department of Oncology
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Southey, M. C., Teo, Z. L. & Winship, I. (2013). PALB2 and breast cancer: ready for clinical translation!. Appl Clin Genet, 6 (2013), pp.43-52. https://doi.org/10.2147/TACG.S34116.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/240873
    DOI
    10.2147/TACG.S34116
    Open Access at PMC
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735037
    Abstract
    For almost two decades, breast cancer clinical genetics has operated in an environment where a heritable cause of breast cancer susceptibility is identified in the vast minority of women seeking advice about their personal and/or family history of breast and/or ovarian cancer. A new wave of genetic information is upon us that promises to provide an explanation for the greater proportion of current missing heritability of breast cancer. Whilst researchers refine bioinformatic and analytic methodology necessary to interpret the new genetic data, attention needs to be paid to defining appropriate and coordinated pathways for the translation of this information so that it can be applied in clinical genetic services for the benefit of the majority of women who currently have no explanation for their breast cancer susceptibility. The search for additional breast cancer susceptibility genes remains a very active area of research. Exhausting the power of linkage studies that identified BRCA1 and BRCA2, the research community moved to candidate gene studies that led to the identification of ATM, BRIP1, CHEK2, and PALB2 as so-called "moderate-risk" breast cancer susceptibility genes. Mutations in these genes are rare and although early reports suggested that, on average, they are associated with moderate risks of breast cancer; population-based studies have demonstrated that at least some mutations in these genes are associated with breast cancer risks that are comparable to the average risk associated with BRCA2 mutations. The search for additional breast cancer susceptibility genes has now moved onto research platforms applying massively parallel sequencing capable of sequencing whole human exomes and genomes in single instrument runs. These programs are identifying a large number of additional putative breast cancer susceptibility genes, many of which are currently undergoing validation. It is highly anticipated that the remaining missing heritability of breast cancer will be due to mutations in many different genes, each explaining a small proportion of the currently unexplained heritable breast cancer susceptibility. The characterization of PALB2 as a breast cancer susceptibility gene and subsequent research that has refined our understanding of the prevalence and penetrance of heritable mutations in PALB2 offers a precious opportunity to use the data as a model and develop modes of translation that would be appropriate for the anticipated volume of imminent new information.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [45689]
    • Sir Peter MacCallum Department of Oncology - Research Publications [728]
    • Medicine and Radiology - Research Publications [2346]
    • Clinical Pathology - Research Publications [385]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors